Skip to content

Efficacy of Ipack Block and Surgeon's Joint Infiltration in Total Knee Arthroplasty

Comparison Between Ipack Block and Periarticular Infiltration in Total Knee Arthroplasty - a Randomized Control Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03653416
Enrollment
99
Registered
2018-08-31
Start date
2018-03-01
Completion date
2019-08-01
Last updated
2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteo Arthritis Knee

Keywords

Total knee arthroplasty, Peri articular infiltration, Pack block, Adductor canal catheter

Brief summary

Total knee arthroplasty(TKA) is an effective modality for the treatment of advanced osteoarthritis of the knee joint with excellent outcomes. With 719,000 cases being performed as of 2010, the incidence is expected to increase up to 3.48 million procedures annually by 2030.

Detailed description

There have been several studies regarding efficacy of peri articular infiltration. IPACK block is a novel technique gaining popularity where one injects local anesthesia safely under ultrasound guidance in the interspace between the popliteal artery and capsule of the knee. There have been no studies till date comparing the efficacy between IPACK block and Periarticular Infiltration (PAI).

Interventions

DEVICEIpack

IPACK block - local anesthesia injected safely under ultrasound guidance in the interspace between the popliteal artery and capsule of the knee.

DRUGBupivacaine

20 cc of bupivacaine(o.25%) injection

PROCEDUREPeri Articular Infiltration

Adductor Canal Catheter and Peri Articular Infiltration

Sponsors

Icahn School of Medicine at Mount Sinai
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* ASA (American Society of Anesthesiology) class I-IV * age 18-75.

Exclusion criteria

* ASA class V * morbid obesity * patient refusal * patients with chronic pain or on pain medication * allergy to LA * patients receiving any additional regional techniques * coagulopathy * patients receiving systemic anticoagulation * local infection and procedures anticipated to last more than 5 hours.

Design outcomes

Primary

MeasureTime frameDescription
Narcotic Consumption24 hoursNarcotic consumption in the first 24 hours

Secondary

MeasureTime frameDescription
Time to First Dose of Narcotic Administrationup to 24 hours
PACU Length of Stayaverage 24 hoursPost-Anesthesia Care Unit (PACU) length of stay (LOS)
Visual Analogue Score (VAS) for Painat 6, 12, 18, and 24 hours post procedureVisual Analogue Score (VAS) for pain - scored from 0 (no pain) to 10 (extreme pain), that is, higher score indicates more pain.
Ambulation DistancePost-op Day 1Ambulation distance with assistance on Post-operative Day (POD) 1 as assessed by PT
Bartels IndexPost-op Day 1Bartels Index to measure activities of daily living (ADL's) on POD 1 as assessed by OT. Total possible scores range from 0-100, with higher scores indicating more independence.
Number of Participants With Pain by Location24 hoursLocation of knee pain as anterior/posterior, medial/lateral

Countries

United States

Participant flow

Recruitment details

Participants enrolled from March 2018, and study conducted from June 2018 to August 2019

Participants by arm

ArmCount
Pai (Peri Articular) Group
Patients received adductor canal catheter and peri articular infiltration.
46
Ipack Group
20 cc of bupivacaine(o.25%) injected with the help of ultrasound guidance. Patients received adductor canal catheter and peri articular infiltration as well. Ipack: IPACK block - local anesthesia injected safely under ultrasound guidance in the interspace between the popliteal artery and capsule of the knee.
46
Total92

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyProtocol Violation61

Baseline characteristics

CharacteristicTotalIpack GroupPai (Peri Articular) Group
Age, Continuous63.66 years
STANDARD_DEVIATION 7.04
64.67 years
STANDARD_DEVIATION 7.72
62.65 years
STANDARD_DEVIATION 6.2
Alcohol Use29 Participants13 Participants16 Participants
Body Mass Index (BMI)32.21 kg/m^2
STANDARD_DEVIATION 6.8
31.74 kg/m^2
STANDARD_DEVIATION 6.34
32.69 kg/m^2
STANDARD_DEVIATION 7.27
Education Level
Bachelor's degree
23 Participants11 Participants12 Participants
Education Level
Graduate degree
16 Participants6 Participants10 Participants
Education Level
High School
53 Participants29 Participants24 Participants
Number of Employed Participants19 Participants3 Participants16 Participants
Race/Ethnicity, Customized
Asian
30 Participants10 Participants20 Participants
Race/Ethnicity, Customized
Black or African American
30 Participants20 Participants10 Participants
Race/Ethnicity, Customized
Hispanic or Latino
16 Participants6 Participants10 Participants
Race/Ethnicity, Customized
White
16 Participants10 Participants6 Participants
Sex: Female, Male
Female
44 Participants14 Participants30 Participants
Sex: Female, Male
Male
48 Participants32 Participants16 Participants
Side of surgery
Left
40 Participants20 Participants20 Participants
Side of surgery
Right
52 Participants26 Participants26 Participants
Smoker6 Participants5 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 460 / 46
other
Total, other adverse events
0 / 460 / 46
serious
Total, serious adverse events
0 / 460 / 46

Outcome results

Primary

Narcotic Consumption

Narcotic consumption in the first 24 hours

Time frame: 24 hours

ArmMeasureValue (MEAN)Dispersion
Ipack GroupNarcotic Consumption15.87 morphine equivalents, mgStandard Deviation 19.75
Pai (Peri Articular) GroupNarcotic Consumption13.67 morphine equivalents, mgStandard Deviation 19.39
Secondary

Ambulation Distance

Ambulation distance with assistance on Post-operative Day (POD) 1 as assessed by PT

Time frame: Post-op Day 1

ArmMeasureValue (MEDIAN)
Ipack GroupAmbulation Distance50 meters
Pai (Peri Articular) GroupAmbulation Distance45 meters
Secondary

Bartels Index

Bartels Index to measure activities of daily living (ADL's) on POD 1 as assessed by OT. Total possible scores range from 0-100, with higher scores indicating more independence.

Time frame: Post-op Day 1

ArmMeasureValue (MEDIAN)
Ipack GroupBartels Index47 score on a scale
Pai (Peri Articular) GroupBartels Index39 score on a scale
Secondary

Number of Participants With Pain by Location

Location of knee pain as anterior/posterior, medial/lateral

Time frame: 24 hours

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Ipack GroupNumber of Participants With Pain by LocationAnterior1 Participants
Ipack GroupNumber of Participants With Pain by LocationLateral10 Participants
Ipack GroupNumber of Participants With Pain by LocationPosterior4 Participants
Ipack GroupNumber of Participants With Pain by LocationKnee4 Participants
Ipack GroupNumber of Participants With Pain by LocationNo Pain22 Participants
Ipack GroupNumber of Participants With Pain by LocationMedial5 Participants
Pai (Peri Articular) GroupNumber of Participants With Pain by LocationNo Pain0 Participants
Pai (Peri Articular) GroupNumber of Participants With Pain by LocationMedial3 Participants
Pai (Peri Articular) GroupNumber of Participants With Pain by LocationAnterior0 Participants
Pai (Peri Articular) GroupNumber of Participants With Pain by LocationKnee18 Participants
Pai (Peri Articular) GroupNumber of Participants With Pain by LocationLateral7 Participants
Pai (Peri Articular) GroupNumber of Participants With Pain by LocationPosterior18 Participants
Secondary

PACU Length of Stay

Post-Anesthesia Care Unit (PACU) length of stay (LOS)

Time frame: average 24 hours

ArmMeasureValue (MEDIAN)
Ipack GroupPACU Length of Stay3.00 hours
Pai (Peri Articular) GroupPACU Length of Stay3.00 hours
Secondary

Time to First Dose of Narcotic Administration

Time frame: up to 24 hours

ArmMeasureValue (MEDIAN)
Ipack GroupTime to First Dose of Narcotic Administration1.5 hours
Pai (Peri Articular) GroupTime to First Dose of Narcotic Administration0.25 hours
Secondary

Visual Analogue Score (VAS) for Pain

Visual Analogue Score (VAS) for pain - scored from 0 (no pain) to 10 (extreme pain), that is, higher score indicates more pain.

Time frame: at 6, 12, 18, and 24 hours post procedure

ArmMeasureGroupValue (MEAN)Dispersion
Ipack GroupVisual Analogue Score (VAS) for Pain6 hours0.93 score on a scaleStandard Deviation 2.05
Ipack GroupVisual Analogue Score (VAS) for Pain12 hours0.76 score on a scaleStandard Deviation 1.62
Ipack GroupVisual Analogue Score (VAS) for Pain18 hours0.74 score on a scaleStandard Deviation 1.93
Ipack GroupVisual Analogue Score (VAS) for Pain24 hours1.50 score on a scaleStandard Deviation 2.53
Pai (Peri Articular) GroupVisual Analogue Score (VAS) for Pain24 hours2.18 score on a scaleStandard Deviation 2.51
Pai (Peri Articular) GroupVisual Analogue Score (VAS) for Pain6 hours0.93 score on a scaleStandard Deviation 2.19
Pai (Peri Articular) GroupVisual Analogue Score (VAS) for Pain18 hours1.41 score on a scaleStandard Deviation 2.21
Pai (Peri Articular) GroupVisual Analogue Score (VAS) for Pain12 hours0.93 score on a scaleStandard Deviation 2.19

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026